Business Solutions & Innovation

Business solutions & innovation is something we are passionate about. It underpins our “can-do” culture and entrepreneurial spirit and is central to not only our organic growth but also a key factor in identifying appropriate M&A targets.


Business Resilience

Business resilience remained a key focus during 2021 as businesses globally were impacted by a full year of Covid-19 and further restrictions. The resilience and dedication of our teams coupled with clear strategic objectives and agility to adapt traditional business models meant the Group was well positioned to continue to deliver for all of our stakeholders. The Group’s diversity in product portfolios and services offerings as well as our digital capabilities were key to the Group’s continued success during 2021.



Uniphar prides itself on its innovative and entrepreneurial culture. This is evident in all areas of the business from implementing improvements in existing systems, identifying new market opportunities, evaluating acquisition targets, and enhancing our digital capabilities.

During 2021, the Group appointed a new Chief Technology Officer, who is tasked with coordinating our digital strategy across the Group. Our digital focus has been a key differentiator for our business and meant that the Group was in a better position to respond to some of the challenges presented by the Covid-19 pandemic. Our new Chief Technology Officer will ensure that the Group has a strategic cohesive digital programme across all divisions and that we are in a position to scale our infrastructure as our business continues to grow and expand geographically.

The acquisition of BESTMSLs Group, headquartered in New York, re- enforces the group’s commitment to deliver innovative solutions for our customers. Among its many services, BESTMSLs Group offer HCPs a digital platform, via it’s ‘Peer Now’ service, to communicate directly with qualified medical science liaisons. While The Doctor’s Channel offers an additional stream, via short online videos, to provide educational material to HCPs relating to specific illnesses and therapeutic areas.

The Group’s multi-channel account management model has evolved further during the year and following the acquisition of E4H now represents a truly ‘Omni-Channel’ approach to commercialising pharma brands. Digital services such as webinars, advisory boards, podcasts & microsites now all form part of the Group’s unique service offering.


Supply Chain Management

As part of our commitment to setting a Science Based Target, we are cognisant of the need to increase engagement with our supply chain on key areas of sustainability, including business ethics and environmental matters. During 2021, the Group commenced work on a supply chain engagement programme including a new Supplier Code of Conduct and Responsible Sourcing Guidelines which the Group intends to roll out during 2022. We appreciate that some of the objectives we have set for ourselves cannot be achieved without meaningful engagement with our supply chain.